782 related articles for article (PubMed ID: 33452570)
1. SARS-CoV-2-associated multisystem inflammatory syndrome in children: clinical manifestations and the role of infliximab treatment.
Abdel-Haq N; Asmar BI; Deza Leon MP; McGrath EJ; Arora HS; Cashen K; Tilford B; Charaf Eddine A; Sethuraman U; Ang JY
Eur J Pediatr; 2021 May; 180(5):1581-1591. PubMed ID: 33452570
[TBL] [Abstract][Full Text] [Related]
2. Infliximab treatment for refractory COVID-19-associated multisystem inflammatory syndrome in a Japanese child.
Yamaguchi Y; Takasawa K; Irabu H; Hiratoko K; Ichigi Y; Hirata K; Tamura Y; Murakoshi M; Yamashita M; Nakatani H; Shimoda M; Ishii T; Udagawa T; Shimizu M; Kanegane H; Morio T
J Infect Chemother; 2022 Jun; 28(6):814-818. PubMed ID: 35125343
[TBL] [Abstract][Full Text] [Related]
3. Multisystem Inflammatory Syndrome Following SARS-CoV-2 Infection in Children: One Year after the Onset of the Pandemic in a High-Incidence Area.
Fabi M; Filice E; Biagi C; Andreozzi L; Palleri D; Mattesini BE; Rizzello A; Gabrielli L; Ghizzi C; Di Luca D; Caramelli F; De Fanti A; Lanari M
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696451
[TBL] [Abstract][Full Text] [Related]
4. Similarities and differences between multiple inflammatory syndrome in children associated with COVID-19 and Kawasaki disease: clinical presentations, diagnosis, and treatment.
Zhang QY; Xu BW; Du JB
World J Pediatr; 2021 Aug; 17(4):335-340. PubMed ID: 34013488
[TBL] [Abstract][Full Text] [Related]
5. Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children.
Lee PY; Day-Lewis M; Henderson LA; Friedman KG; Lo J; Roberts JE; Lo MS; Platt CD; Chou J; Hoyt KJ; Baker AL; Banzon TM; Chang MH; Cohen E; de Ferranti SD; Dionne A; Habiballah S; Halyabar O; Hausmann JS; Hazen MM; Janssen E; Meidan E; Nelson RW; Nguyen AA; Sundel RP; Dedeoglu F; Nigrovic PA; Newburger JW; Son MBF
J Clin Invest; 2020 Nov; 130(11):5942-5950. PubMed ID: 32701511
[TBL] [Abstract][Full Text] [Related]
6. Phenotype, Susceptibility, Autoimmunity, and Immunotherapy Between Kawasaki Disease and Coronavirus Disease-19 Associated Multisystem Inflammatory Syndrome in Children.
Chen MR; Kuo HC; Lee YJ; Chi H; Li SC; Lee HC; Yang KD
Front Immunol; 2021; 12():632890. PubMed ID: 33732254
[TBL] [Abstract][Full Text] [Related]
7. Characterizing the differences between multisystem inflammatory syndrome in children and Kawasaki disease.
Bar-Meir M; Guri A; Godfrey ME; Shack AR; Hashkes PJ; Goldzweig O; Megged O
Sci Rep; 2021 Jul; 11(1):13840. PubMed ID: 34226639
[TBL] [Abstract][Full Text] [Related]
8. Multisystem Inflammatory Syndrome in Children Associated with COVID-19: A Review with an Emphasis on Mucocutaneous and Kawasaki Disease-Like Findings.
Marzano AV; Cassano N; Moltrasio C; Verdoni L; Genovese G; Vena GA
Dermatology; 2022; 238(1):35-43. PubMed ID: 34062530
[TBL] [Abstract][Full Text] [Related]
9. Defining Kawasaki disease and pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection during SARS-CoV-2 epidemic in Italy: results from a national, multicenter survey.
Cattalini M; Della Paolera S; Zunica F; Bracaglia C; Giangreco M; Verdoni L; Meini A; Sottile R; Caorsi R; Zuccotti G; Fabi M; Montin D; Meneghel A; Consolaro A; Dellepiane RM; Maggio MC; La Torre F; Marchesi A; Simonini G; Villani A; Cimaz R; Ravelli A; Taddio A;
Pediatr Rheumatol Online J; 2021 Mar; 19(1):29. PubMed ID: 33726806
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 associated multisystemic inflammatory syndrome in 614 children with and without overlap with Kawasaki disease-Turk MIS-C study group.
Yilmaz Ciftdogan D; Ekemen Keles Y; Cetin BS; Dalgic Karabulut N; Emiroglu M; Bagci Z; Buyukcam A; Erdeniz EH; Arga G; Yesil E; Cakici O; Karbuz A; Sahbudak Bal Z; Kara SS; Ozer A; Metin Akcan O; Elmas Bozdemir S; Anil AB; Uygun H; Kilic O; Hancerli Torun S; Umit Z; Sutcu M; Ozgokce Ozmen B; Karaoglu Asrak H; Alkan G; Kara Aksay A; Ugur C; Birbilen AZ; Bursal Duramaz B; Akyuz Ozkan E; Burakay O; Yildirim Arslan S; Karadag Oncel E; Celik SF; Kilic AO; Ozen S; Sarikaya R; Demirkol D; Arslan G; Turel O; Sert A; Sari E; Orbak Z; Sahin IO; Varan C; Akturk H; Tuter Oz SK; Durak F; Oflaz MB; Kara M; Karpuz D; Talip Petmezci M; Hatipoglu N; Oncel S; Turgut M; Elmali F; Somer A; Kuyucu N; Dinleyici EC; Kurugöl Z; Ciftci E; Kara A
Eur J Pediatr; 2022 May; 181(5):2031-2043. PubMed ID: 35129668
[TBL] [Abstract][Full Text] [Related]
11. Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2.
Whittaker E; Bamford A; Kenny J; Kaforou M; Jones CE; Shah P; Ramnarayan P; Fraisse A; Miller O; Davies P; Kucera F; Brierley J; McDougall M; Carter M; Tremoulet A; Shimizu C; Herberg J; Burns JC; Lyall H; Levin M;
JAMA; 2020 Jul; 324(3):259-269. PubMed ID: 32511692
[TBL] [Abstract][Full Text] [Related]
12. Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management.
Kabeerdoss J; Pilania RK; Karkhele R; Kumar TS; Danda D; Singh S
Rheumatol Int; 2021 Jan; 41(1):19-32. PubMed ID: 33219837
[TBL] [Abstract][Full Text] [Related]
13. Multisystem Inflammatory Syndrome in Children (MIS-C).
Patel JM
Curr Allergy Asthma Rep; 2022 May; 22(5):53-60. PubMed ID: 35314921
[TBL] [Abstract][Full Text] [Related]
14. A machine-learning algorithm for diagnosis of multisystem inflammatory syndrome in children and Kawasaki disease in the USA: a retrospective model development and validation study.
Lam JY; Shimizu C; Tremoulet AH; Bainto E; Roberts SC; Sivilay N; Gardiner MA; Kanegaye JT; Hogan AH; Salazar JC; Mohandas S; Szmuszkovicz JR; Mahanta S; Dionne A; Newburger JW; Ansusinha E; DeBiasi RL; Hao S; Ling XB; Cohen HJ; Nemati S; Burns JC; ;
Lancet Digit Health; 2022 Oct; 4(10):e717-e726. PubMed ID: 36150781
[TBL] [Abstract][Full Text] [Related]
15. Multisystem inflammatory syndrome (MIS-C) in Pakistani children: A description of the phenotypes and comparison with historical cohorts of children with Kawasaki disease and myocarditis.
Mohsin SS; Abbas Q; Chowdhary D; Khalid F; Sheikh AS; Ali Khan ZG; Aslam N; Bhatti OA; Inam M; Saleem AF; Bhutta AT
PLoS One; 2021; 16(6):e0253625. PubMed ID: 34153080
[TBL] [Abstract][Full Text] [Related]
16. [Clinical analysis of 11 cases multisystem inflammatory syndrome associated with SARS-CoV-2 Omicron variant infection in children].
Zhang HS; Chang XT; Wu PH; Song DY; Ge G; Ding W; Hu ZW; Wang GF; Jiang YW; Ye LP
Zhonghua Er Ke Za Zhi; 2024 Jan; 62(1):55-59. PubMed ID: 38154978
[No Abstract] [Full Text] [Related]
17. Multisystem inflammatory syndrome in children (MIS-C): A nationwide collaborative study in the Greek population.
Lampidi S; Maritsi D; Charakida M; Eleftheriou I; Farmaki E; Spyridis N; Charisi K; Vantsi P; Filippatos F; Skourti K; Papadopoulou-Alataki E; Papadopoulou-Legbelou K; Kampouridou P; Grivea IN; Vergadi E; Gkentzi D; Dimou D; Koletsi P; Fotis L; Liakopoulou T; Agrafiotou A; Kourtesi K; Tsolas G; Kafetzis D; Papaevangelou V; Dimitriou G; Galanakis E; Syrogiannopoulos GA; Spoulou V; Michos A; Roilides E; Tsolia MN
Eur J Pediatr; 2024 Apr; 183(4):1693-1702. PubMed ID: 38214810
[TBL] [Abstract][Full Text] [Related]
18. Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial.
Burns JC; Roberts SC; Tremoulet AH; He F; Printz BF; Ashouri N; Jain SS; Michalik DE; Sharma K; Truong DT; Wood JB; Kim KK; Jain S;
Lancet Child Adolesc Health; 2021 Dec; 5(12):852-861. PubMed ID: 34715057
[TBL] [Abstract][Full Text] [Related]
19. Childhood multisystem inflammatory syndrome associated with COVID-19 (MIS-C): Distinct from Kawasaki disease or part of the same spectrum?
Santaniello M; Matucci-Cerinic C; Natoli V; Trincianti C; Ridella F; Ravelli A
Pediatr Allergy Immunol; 2022 Jan; 33 Suppl 27(Suppl 27):102-104. PubMed ID: 35080303
[TBL] [Abstract][Full Text] [Related]
20. The Kawasaki Disease Comparative Effectiveness (KIDCARE) trial: A phase III, randomized trial of second intravenous immunoglobulin versus infliximab for resistant Kawasaki disease.
Roberts SC; Jain S; Tremoulet AH; Kim KK; Burns JC; ; Anand V; Anderson M; Ang J; Ansusinha E; Arditi M; Ashouri N; Bartlett A; Chatterjee A; DeBiasi R; Dekker C; DeZure C; Didion L; Dominguez S; El Feghaly R; Erdem G; Halasa N; Harahsheh A; Jackson MA; Jaggi P; Jain S; Jone PN; Kaushik N; Kurio G; Lillian A; Lloyd D; Manaloor J; McNelis A; Michalik DE; Newburger J; Newcomer C; Perkins T; Portman M; Romero J; Ronis T; Rowley A; Schneider K; Schuster J; Tejtel SKS; Sharma K; Simonsen K; Szmuszkovicz J; Truong D; Wood J; Yeh S
Contemp Clin Trials; 2019 Apr; 79():98-103. PubMed ID: 30840903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
